## Abstract Amide proton transfer (APT) imaging employs the chemical exchange saturation transfer (CEST) mechanism to detect mobile endogenous proteins and peptides. It can be used to detect pH reduction during acute ischemia and thus provide complementary information to perfusion‐weighted (PWI) an
Amide proton transfer (APT) contrast for imaging of brain tumors
✍ Scribed by Jinyuan Zhou; Bachchu Lal; David A. Wilson; John Laterra; Peter C.M. van Zijl
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 376 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In this work we demonstrate that specific MR image contrast can be produced in the water signal that reflects endogenous cellular protein and peptide content in intracranial rat 9L gliosarcomas. Although the concentration of these mobile proteins and peptides is only in the millimolar range, a detection sensitivity of several percent on the water signal (molar concentration) was achieved. This was accomplished with detection sensitivity enhancement by selective radiofrequency (RF) labeling of the amide protons, and by utilizing the effective transfer of this label to water via hydrogen exchange. Brain tumors were also assessed by conventional T~1~‐weighted, T~2~‐weighted, and diffusion‐weighted imaging. Whereas these commonly‐used approaches yielded heterogeneous images, the new amide proton transfer (APT) technique showed a single well‐defined region of hyperintensity that was assigned to brain tumor tissue. Magn Reson Med 50:1120–1126, 2003. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract T~1~‐weighted magnetic resonance imaging (MRI) was used to evaluate the potential interest of a new Gd‐based contrast agent, termed P760, to characterize brain tumor heterogeneity and vascularization and to delineate regions containing permeable vessels. The C6 rat glioma model was used